08/30/2017

NCCN has published updates to the NCCN Guidelines® and the NCCN Compendium® for Ovarian Cancer

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium^®) for Ovarian Cancer. These NCCN Guidelines^® are currently available as Version 3.2017. 

• Complete Remission and Relapse ≥6 months After Completing Prior Chemotherapy (OV-6)
  • Olaparib has been added as a maintenance therapy option for consideration if there is a partial or complete response after two or more lines of platinum-based therapy for those with platinum-sensitive disease.

NCCN has published the following updated NCCN Guidelines^® with NCCN Evidence Blocks™:  

Ovarian Cancer, Version 3.2017